Teriflunomide reduces clinical events in radiologically isolated syndrome, finds study

For adults with radiologically isolated syndrome (RIS), teriflunomide is associated with a reduction in the first clinical demyelinating event compared with placebo, according to a study presented at the annual meeting of the American Academy of Neurology, held from April 22 to 27 in Boston.

Leave A Comment

Your email address will not be published. Required fields are marked *